Amgen's point of view on epoetins
- PMID: 15050950
- DOI: 10.1016/S1470-2045(04)01422-6
Amgen's point of view on epoetins
Comment on
-
Breast cancer trial with erythropoietin terminated unexpectedly.Lancet Oncol. 2003 Aug;4(8):459-60. doi: 10.1016/s1470-2045(03)01163-x. Lancet Oncol. 2003. PMID: 12901958 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
